Published

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology
Date: 2019-06-01
Source: Crossref
DOI: 10.1038/s41386-019-0324-9
PubMed: 30685771

Authors

Madsen Martin K.Fisher Patrick M.Burmester Daniel Dyssegaard Agnete Stenbæk Dea S.Kristiansen Sara Johansen Sys S.Lehel Sczabolz Linnet Kristian Svarer Claus Erritzoe David Ozenne Brice Knudsen Gitte M.

Watch author

Derived topics and classifications

psilocybin psilocin Receptor Pharmacology Other

Citation graph

40 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

10.1007/bf02159243 10.1007/bf00412109 10.1177/0269881116675513 10.1177/0269881116675512 10.1177/0269881114548296 10.1177/0269881114565144 10.1016/j.neuron.2007.01.008 10.1016/j.biopsych.2012.04.005 10.1097/00001756-199812010-00024 10.1016/s1569-7339(10)70102-8 10.1038/sj.jcbfm.9600493 10.1006/nimg.1996.0066

Indexed papers citing this DOI

Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks2026-08-17 The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis2026-08-01 Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex2026-07-28 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia2026-07-18 α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice2026-07-07 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review2026-07-01 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats2026-07-01 Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18 Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry2026-06-04 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy2026-05-28 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14 The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus2026-05-07 Human brain changes after first psilocybin use2026-05-05 Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms2026-05-01 Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine2026-05-01 Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia2026-04-24

Related papers

No close related records were found yet.